CVC Capital Partners is seeking a buyer for its 60% stake in Genetic Group, aiming to raise €700m. The Italian pharmaceutical company, founded by Rocco Pavese, specializes in medical devices and has seen significant earnings growth since CVC's acquisition in 2020. Additionally, CVC DIF is acquiring a 49.9% stake in Singapore's ECO, a hazardous waste management firm, marking its first investment in Southeast Asia. Teljes cikk (Euronews.com)